Etihad Airways is partnering with Austrian-based healthcare technology company Medicus AI to launch a COVID-19 risk-assessment tool that will empower passengers to make informed decisions about traveling.
Powered by Medicus AI’s technology, the risk-assessment tool will guide Etihad’s passengers in evaluating the probability of having contracted the COVID-19 coronavirus by responding to a set of 22 questions.
The self-administered assessment, which takes less than five minutes to complete, is based on World Health Organisation (WHO) guidelines that are updated daily.
With this risk-assessment tool, passengers will understand their individual probability of having contracted the virus alongside advisories and recommendations, allowing them to make informed decisions about traveling.
Frank Meyer, Chief Digital Officer, Etihad Airways, said: “As flying operations begin to resume globally, we want to empower our guests to make informed decisions on travel. Partnering with Medicus AI on this innovative new tool is just one of the ways we are adapting our operations and guest experience to meet the new demands placed on the travel industry as a result of COVID-19.”
Dr. Baher Al Hakim, Chief Executive Officer, Medicus AI, said: “We are proud to support Etihad Airways in their efforts to ensure the safety of its passengers and crew as the world returns to normalcy. Our initial efforts at the start of the pandemic were to help provide assessment and monitoring tools, and as needs shift, our efforts have evolved to help our partners bring people back to their day-to-day life in a safe manner.”
The tool is now available to passengers on Etihad.com and soon on the Etihad Airways mobile application on the Apple iOS, Android and Huawei platforms, and will be accessible in English, with additional language editions such as Arabic, French, German and Portuguese being added in phases.